Although the device is not available for evaluation, investigation to determine a potential malfunction is pending.A review was performed by alere's medical advisor to determine if there is any association between the inratio device and the event.Based on the information provided, including the physician's statement that indicated bleeding did not contribute to the patient's death but that the cause of death was heart failure, there is no reasonable suspicion that the inratio device caused or contributed to the patient's death.
|
A physician customer reported two variances between a patient's inratio inr results from poc testing and laboratory inr results.Both reported discrepant results were obtained during the same week (exact dates unknown).The results are as follows: event 1: inratio 1.9, lab >5.8, event 2: inratio 2.1, lab >8.Patient's therapeutic range was: 2-3.Patient was hospitalized on (b)(6) 2015 and given vitamin k.According to the physician, the patient was multimorbid, suffering from many different diseases including renal insufficiency and water in the lung.The physician reported that the patient died from heart failure and that the death was not due to a bleed.The physician also reported that the patient's hematocrit was 38% prior to hospitalization and 39% in the hospital (range per package insert is 25-53%).Although requested, no additional information about the hospital, hospitalization dates, or date of death could be obtained, nor could a copy of the patient's death certificate be obtained.Note: this mdr filing is due to the device being the same or similar to a device available in the us.
|